A Noval Established Cuproptosis-Associated LncRNA Signature for Prognosis Prediction in Primary Hepatic Carcinoma

<div>(a) Survival nomogram on risk score and stage. (b) Concordance index on risk score and stage. (c) ROC curve comparing the prognostic power of the nomogram at 1, 3, and 5 years for the entire cohort. (d) Calibration curves were corrected for predicting liver cancer patients at 1, 3, and 5 years for the entire cohort.</div>

Evidence-Based Complementary and Alternative Medicine

fig6

Figure 6

Figure 6: A Noval Established Cuproptosis-Associated LncRNA Signature for Prognosis Prediction in Primary Hepatic Carcinoma 